6O2X
Structure of cruzain bound to MMTS inhibitor
Summary for 6O2X
Entry DOI | 10.2210/pdb6o2x/pdb |
Descriptor | Cruzipain, 1,2-ETHANEDIOL, PHOSPHATE ION, ... (4 entities in total) |
Functional Keywords | cysteine protease, autocatalytic cleavage, protease, hydrolase |
Biological source | Trypanosoma cruzi |
Total number of polymer chains | 2 |
Total formula weight | 45989.83 |
Authors | Silva, E.B.,Dall, E.,Ferreira, R.S.,Brandstetter, H. (deposition date: 2019-02-25, release date: 2019-05-29, Last modification date: 2023-10-11) |
Primary citation | Barbosa da Silva, E.,Dall, E.,Briza, P.,Brandstetter, H.,Ferreira, R.S. Cruzain structures: apocruzain and cruzain bound to S-methyl thiomethanesulfonate and implications for drug design. Acta Crystallogr.,Sect.F, 75:419-427, 2019 Cited by PubMed Abstract: Chagas disease, which is caused by Trypanosoma cruzi, affects more than six million people worldwide. Cruzain is the major cysteine protease involved in the survival of this parasite. Here, the expression, purification and crystallization of this enzyme are reported. The cruzain crystals diffracted to 1.2 Å resolution, yielding two novel cruzain structures: apocruzain and cruzain bound to the reversible covalent inhibitor S-methyl thiomethanesulfonate. Mass-spectrometric experiments confirmed the presence of a methylthiol group attached to the catalytic cysteine. Comparison of these structures with previously published structures indicates the rigidity of the cruzain structure. These results provide further structural information about the enzyme and may help in new in silico studies to identify or optimize novel prototypes of cruzain inhibitors. PubMed: 31204688DOI: 10.1107/S2053230X19006320 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.193 Å) |
Structure validation
Download full validation report
